SKLB 1028 [1350544-93-2]

TargetMol Chemicals

SKLB 1028 [1350544-93-2]

4

1350544-93-2

Research Use Only

SKLB 1028

99.85%

C24H29N9

443.55

SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.

3 years

C(C)(C)N1C=2C(N=C1NC=3C=CC=NC3)=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N2

-20°C

12352200